« Previous Next » Biology of Blood and Marrow Transplantation
Volume 13, Issue 1 , Pages 90-99 , January 2007

Allogeneic Bone Marrow Transplantation from Unrelated Human T-Cell Leukemia Virus-I–negative Donors for Adult T-Cell Leukemia/Lymphoma: Retrospective Analysis of Data from the Japan Marrow Donor Program

Koji Kato
- Department of Hematology, Hamanomachi General Hospital, Fukuoka, Japan
- Adult Blood and Marrow Transplantation program, University of Michigan Comprehensive Cancer Center, Michigan
- Correspondence and reprint requests: Koji Kato, MD, PhD, Adult Blood and Marrow Transplantation Program, University of Michigan Comprehensive Cancer Center 5303 CCGC 1500E. Medical Center Drive, Ann Arbor, MI 48109-0914.
Yoshinobu Kanda
- Department of Cell Therapy and Transplantation Medicine, University of Tokyo, Tokyo, Japan
Tetsuya Eto
- Department of Hematology, Hamanomachi General Hospital, Fukuoka, Japan
Tsuyoshi Muta
- Department of Hematology, Hamanomachi General Hospital, Fukuoka, Japan
Hisashi Gondo
- Department of Hematology, Hamanomachi General Hospital, Fukuoka, Japan
Shuichi Taniguchi
- Department of Hematology, Toranomon General Hospital, Tokyo, Japan
Tsunefumi Shibuya
- Department of Hematology, Hamanomachi General Hospital, Fukuoka, Japan
Atae Utsunomiya
- Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
Takakazu Kawase
- Division of Immunology, Aichi Cancer Center Research Institute, Aichi, Japan
Shunichi Kato
- Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine, Kanagawa, Japan
Yasuo Morishima
- Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Aichi, Japan
Yoshihisa Kodera
- Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital, Aichi, Japan
Mine Harada
- Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan
Japan Marrow Donor Program

Cumulative incidence of grade II–IV acute GVHD in patients who achieved neutrophil engraftment.

Cumulative incidence of grade II–IV acute GVHD in patients who achieved neutrophil engraftment.
- Full-Size Image
- Download to PowerPoint
Probability of progression-free survival (A) and overall survival (B) after unrelated bone marrow transplantation for adult T-cell leukemia/lymphoma. Dashed lines represent 95% confidence intervals.

Probability of progression-free survival (A) and overall survival (B) after unrelated bone marrow transplantation for adult T-cell leukemia/lymphoma. Dashed lines represent 95% confidence intervals.
- Full-Size Image
- Download to PowerPoint
Overall survival according to pretransplantation factors, age (A) and disease status at transplantation (B).

Overall survival according to pretransplantation factors, age (A) and disease status at transplantation (B).
- Full-Size Image
- Download to PowerPoint
Cumulative incidence of disease progression (—) and progression-free mortality (---) after transplantation.

Cumulative incidence of disease progression (—) and progression-free mortality (---) after transplantation.
- Full-Size Image
- Download to PowerPoint
Cumulative incidence of progression-free mortality grouped according to pretransplantation factors, age (A) and disease status at transplantation (B).

Cumulative incidence of progression-free mortality grouped according to pretransplantation factors, age (A) and disease status at transplantation (B).
- Full-Size Image
- Download to PowerPoint